Zinger Key Points
- The move comes after StateHouse Holdings defaulted on four loans, prompting Pelorus, to seek court intervention.i
- StateHouse reported in August a 10% year-over-year revenue increase for the second quarter of 2024.
- Feel unsure about the market’s next move? Copy trade alerts from Matt Maley—a Wall Street veteran who consistently finds profits in volatile markets. Claim your 7-day free trial now.
In a significant move within California's cannabis industry, Pelorus Fund REIT, LLC has filed a complaint in the Superior Court of California, requesting the appointment of a receiver to oversee StateHouse Holdings Inc.
The move comes after StateHouse STHZF defaulted on four loans, prompting Pelorus, a major creditor, to seek court intervention.
According to Dan Leimel Jr., CEO of Pelorus, the receivership aims to safeguard StateHouse’s operations, employees and assets while restructuring the company for enhanced efficiency and product delivery. “We recognize the inherent value in the Company’s operations, employees, and assets,” Leimel stated, underlining the intention to protect all stakeholders involved.
- Get Benzinga’s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. You can't afford to miss out if you’re serious about the business.
StateHouse’s Mixed Financial Outlook
Despite the turmoil surrounding its financial stability, in August StateHouse Holdings reported a 10% year-over-year revenue increase for the second quarter of 2024.
Revenue reached $27.8 million, compared to $25.3 million in Q2 2023, with net income climbing to $200,000 from a $2.1 million loss the previous year. CEO Ed Schmults attributed this growth to innovative product launches and effective cost-saving measures, resulting in a gross margin improvement of 50.8%.
However, the company’s financial health remains precarious, marked by a net working capital deficiency of approximately $156 million. As it navigates these challenges, the company continues to expand its product offerings, having launched 24 new products in the past year, which now account for 15% of its sales for 2024.
Read Next: Nasdaq-Listed Vaping Company Ispire Reports 31% YoY Increase In 2024 Revenue
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!